Regina Berkovich

717 total citations
33 papers, 469 citations indexed

About

Regina Berkovich is a scholar working on Pathology and Forensic Medicine, Neurology and Immunology. According to data from OpenAlex, Regina Berkovich has authored 33 papers receiving a total of 469 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Pathology and Forensic Medicine, 9 papers in Neurology and 7 papers in Immunology. Recurrent topics in Regina Berkovich's work include Multiple Sclerosis Research Studies (25 papers), Peripheral Neuropathies and Disorders (5 papers) and Migraine and Headache Studies (4 papers). Regina Berkovich is often cited by papers focused on Multiple Sclerosis Research Studies (25 papers), Peripheral Neuropathies and Disorders (5 papers) and Migraine and Headache Studies (4 papers). Regina Berkovich collaborates with scholars based in United States, Canada and Russia. Regina Berkovich's co-authors include Mark Agius, Leslie P. Weiner, Mone Zaidi, Anna Catania, Robert P. Lisak, B. G. W. Arnason, Lawrence Steinman, Ann Bass, Zia Choudhry and Nadia Daizadeh and has published in prestigious journals such as Neurology, Brain Research and Frontiers in Immunology.

In The Last Decade

Regina Berkovich

29 papers receiving 450 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Regina Berkovich United States 10 335 153 97 85 83 33 469
Astrid Edland Norway 12 289 0.9× 118 0.8× 74 0.8× 115 1.4× 50 0.6× 16 509
Jonathan L. Carter United States 7 271 0.8× 116 0.8× 73 0.8× 56 0.7× 95 1.1× 12 468
Dian He China 16 363 1.1× 224 1.5× 44 0.5× 69 0.8× 85 1.0× 49 669
Fonda Liu United States 5 275 0.8× 112 0.7× 44 0.5× 71 0.8× 47 0.6× 9 457
Naeem Mahfooz United States 7 150 0.4× 45 0.3× 27 0.3× 81 1.0× 44 0.5× 11 302
M. Rieks Germany 7 141 0.4× 47 0.3× 64 0.7× 22 0.3× 102 1.2× 9 453
Zhiyun Lian China 10 186 0.6× 150 1.0× 18 0.2× 40 0.5× 50 0.6× 22 286
Kimberly M. Winges United States 9 176 0.5× 74 0.5× 29 0.3× 50 0.6× 70 0.8× 14 353
V. Argentiero Italy 9 70 0.2× 129 0.8× 43 0.4× 34 0.4× 86 1.0× 16 523
G. Niederwieser Austria 10 165 0.5× 194 1.3× 73 0.8× 107 1.3× 92 1.1× 15 546

Countries citing papers authored by Regina Berkovich

Since Specialization
Citations

This map shows the geographic impact of Regina Berkovich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Regina Berkovich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Regina Berkovich more than expected).

Fields of papers citing papers by Regina Berkovich

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Regina Berkovich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Regina Berkovich. The network helps show where Regina Berkovich may publish in the future.

Co-authorship network of co-authors of Regina Berkovich

This figure shows the co-authorship network connecting the top 25 collaborators of Regina Berkovich. A scholar is included among the top collaborators of Regina Berkovich based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Regina Berkovich. Regina Berkovich is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mirsaeidi, Mehdi, et al.. (2025). A Narrative Review of the Immunomodulatory Effects of Acthar® Gel Beyond Its Steroidogenic Properties. Advances in Therapy. 42(11). 5365–5379.
2.
Berkovich, Regina, et al.. (2025). Switching to ublituximab from prior anti-CD20 monoclonal antibody therapy: a case report series. Frontiers in Immunology. 16. 1527102–1527102. 1 indexed citations
3.
Berkovich, Regina, et al.. (2024). Cross-prevalence of multiple sclerosis and stroke evaluated on cohorts of four independent specialty medical centers. Multiple Sclerosis and Related Disorders. 90. 105772–105772.
4.
Berkovich, Regina, et al.. (2023). Menthol dural application alters meningeal arteries tone and enhances excitability of trigeminocervical neurons in rats. Brain Research. 1825. 148725–148725. 2 indexed citations
5.
Foley, John, Regina Berkovich, Mark Gudesblatt, et al.. (2022). Characterizing the ‘feel-good experience’ in Multiple Sclerosis Patients Treated With Natalizumab Or Other Therapies. Neurodegenerative Disease Management. 13(1). 23–34. 5 indexed citations
6.
Berkovich, Regina, et al.. (2021). Progressive Multifocal Leukoencephalopathy Risk Perception in Patients Considering Natalizumab for Multiple Sclerosis. International Journal of MS Care. 24(1). 13–17. 1 indexed citations
7.
Steingo, Brian, Yaser Al Malik, Ann Bass, et al.. (2020). Long-term efficacy and safety of alemtuzumab in patients with RRMS: 12-year follow-up of CAMMS223. Journal of Neurology. 267(11). 3343–3353. 41 indexed citations
8.
9.
10.
11.
Berkovich, Regina. (2017). Clinical and MRI outcomes after stopping or switching disease-modifying therapy in stable MS patients: a case series report. Multiple Sclerosis and Related Disorders. 17. 123–127. 12 indexed citations
12.
13.
14.
Krieger, Stephen, B. Singer, Mark S. Freedman, et al.. (2016). Treatment-Naive Patients with Highly Active RRMS Demonstrated Durable Efficacy with Alemtuzumab over 5 Years (S51.003). Neurology. 86(16_supplement). 7 indexed citations
15.
LaGanke, Christopher, Regina Berkovich, Jeffrey Cohen, et al.. (2015). Durable Effect of Alemtuzumab on Disability Improvement in Patients With Relapsing-Remitting Multiple Sclerosis Who Relapsed on a Prior Therapy (P3.261). Neurology. 84(14_supplement). 2 indexed citations
16.
Berkovich, Regina, Daniel M. Togasaki, Steven Cen, & Lawrence Steinman. (2015). CD4 cell response to interval therapy with natalizumab. Annals of Clinical and Translational Neurology. 2(5). 570–574. 6 indexed citations
17.
Berkovich, Regina & Leslie P. Weiner. (2015). Effects of dimethyl fumarate on lymphocyte subsets. Multiple Sclerosis and Related Disorders. 4(4). 339–341. 39 indexed citations
18.
Lyubashina, O. A., et al.. (2013). Intravenous valproate inhibits ongoing and evoked activity of dura-sensitive thalamic neurons in rats. European Journal of Pharmacology. 715(1-3). 204–211. 9 indexed citations
19.
Arnason, B. G. W., Regina Berkovich, Anna Catania, Robert P. Lisak, & Mone Zaidi. (2012). Mechanisms of action of adrenocorticotropic hormone and other melanocortins relevant to the clinical management of patients with multiple sclerosis. Multiple Sclerosis Journal. 19(2). 130–136. 62 indexed citations
20.
Berkovich, Regina, et al.. (2011). Autoimmune Comorbid Conditions in Multiple Sclerosis. 7(2). 132–132. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Astrid Edland Breakdown of academic impact, for papers by Jonathan L. Carter Breakdown of academic impact, for papers by Dian He Breakdown of academic impact, for papers by Fonda Liu Breakdown of academic impact, for papers by Naeem Mahfooz Breakdown of academic impact, for papers by M. Rieks Breakdown of academic impact, for papers by Zhiyun Lian Breakdown of academic impact, for papers by Kimberly M. Winges Breakdown of academic impact, for papers by V. Argentiero Breakdown of academic impact, for papers by G. Niederwieser
Rankless by CCL
2026